Harrow Health engages in the development, production and sale of medications. Co. owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical businesses. Through its subsidiaries, Visionology, Inc., which provides an online eye health platform; Surface Ophthalmics, Inc., which is focused on development and commercialization of therapeutics for ocular surface diseases; and Melt Pharmaceuticals, Inc., which is focused on the development and commercialization of proprietary non-intravenous, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. When considering the Harrow Health Inc stock dividend history, we have taken known splits into account, such that the HROW dividend history is presented on a split-adjusted ("apples to apples") basis. Harrow Health Inc dividend history is presented both in graphical/chart form, and as a HROW dividend history data table along the right-hand column.